All Japan articles – Page 2
-
BusinessMitsubishi Tanabe Pharma buys Neuroderm for $1.1 billion
Japanese pharmaceutical giant to acquire Israel’s Neuroderm in record breaking deal
-
BusinessDaiichi Sankyo to close R&D sites in India and Japan
Closures are part of an ongoing reorganisation aimed at increasing productivity
-
OpinionWhy speaking English could revitalise Japanese science
Language could solve the stagnation seen in undergraduate courses
-
FeatureWhat it takes to make a new element
Yuri Oganessian tells us how nihonium, moscovium, tennessine and oganesson were made
-
BusinessBrexit could push Japanese pharma out of the UK
Warnings that Japanese R&D investment in the UK is endangered by plans to leave the EU
-
-
NewsExplosive end for Japan's second world war chemical weapons
Bombs and mortars abandoned by retreating Japanese troops in China are finally being destroyed
-
CareersThe asymmetry problem
Reiko Kuroda has been tackling asymmetry her whole life, from molecular chirality to gender inequality, she tells James Mitchell Crow
-
Business
Deadly explosion at Japanese silicon plant
Five killed and several more injured at Mitsubishi Materials site
-
Business
Japanese chemicals show signs of recovery
Reconstruction after 2011 disaster drives higher demand
-
NewsChina blamed for mercury on iconic Mount Fuji
Pollution research adds to simmering row between Japan and China over disputed islands
-
Business
Japan confirms Novartis clinical trial data fabrication
Investigation into blood pressure blockbuster continues
-
OpinionThe Choshu five
Alwyn Davies recounts how five Japanese students and their chemist mentor changed Japanese society forever
-
NewsFukushima disaster has not raised cancer risks, says UN
Latest study at odds with others that predicted a slight increase in certain types of tumours
-
Business
Japanese pharma opens compound vaults
Molecule libraries to be screened for neglected diseases
-
NewsFukushima disaster predicted to raise cancer rates slightly
World Health Organization report expects cancer risk to rise marginally, but doesn’t put a figure on the number of deaths expected
-
NewsRebuilding public trust in Japanese science
Public faith in the role of science-based decision-making faltered after the tsunami and Fukushima and won’t be easy recover
-
News
Methane hydrate success
The US and Japan have successfully completed their trial of methane hydrate production technologies
-
Opinion
Breaking the surface?
Philip Ball is perplexed by the EPSRC’s decision to cut surface science funding
-
News
Quake-hit Japanese universities move on
Among the universities damaged by the earthquake, by far the hardest hit was Tohoku University
- Previous Page
- Page1
- Page2
- Next Page